Source:http://linkedlifedata.com/resource/pubmed/id/16038707
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-7-25
|
pubmed:abstractText |
Thrombin exerts multiple actions on cardiomyocytes leading to increased intracellular Na+ and Ca2+ concentrations, and to activation of a Ca2+-independent PLA2, and has been proposed to favor the genesis of arrhythmias and ischemic injury in acute coronary syndromes. However, the influence of thrombin on cardiomyocyte cell death during ischemia-reperfusion has not been studied. A beneficial influence of low thrombin concentrations has been described in other cell types. HL-1 cardiomyocytes were subjected to simulated ischemia (SI) and reperfusion (SR) and cell death was assessed by means of LDH release to the incubation media. Thrombin dose-dependently increased cell death in normoxic cells, in cells subjected to SI, and in cells subjected to SR (by 20+/-8%, 95+/-32% and 35+/-9%, respectively, at 100 U/ml). The effects of thrombin were associated to increased cytosolic Ca2+ overload, mimicked by 100 microM PAR-1 agonist peptide SFLLRNPNDKYEPF, and reversed by the direct thrombin inhibitor lepirudin (IC50=1.3+/-0.2 microg/ml). The presence of thrombin during simulated ischemia-reperfusion increases cardiomyocyte cell death by a mechanism that involves activation of PAR-1 receptors and can be prevented by the direct thrombin inhibitor lepirudin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/D-lactate dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Digitonin,
http://linkedlifedata.com/resource/pubmed/chemical/Hirudins,
http://linkedlifedata.com/resource/pubmed/chemical/Lactate Dehydrogenases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin,
http://linkedlifedata.com/resource/pubmed/chemical/lepirudin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2828
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
277-83
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16038707-Animals,
pubmed-meshheading:16038707-Calcium Signaling,
pubmed-meshheading:16038707-Cell Death,
pubmed-meshheading:16038707-Cells, Cultured,
pubmed-meshheading:16038707-Digitonin,
pubmed-meshheading:16038707-Hirudins,
pubmed-meshheading:16038707-Lactate Dehydrogenases,
pubmed-meshheading:16038707-Mice,
pubmed-meshheading:16038707-Mice, Transgenic,
pubmed-meshheading:16038707-Myocardial Ischemia,
pubmed-meshheading:16038707-Myocardial Reperfusion Injury,
pubmed-meshheading:16038707-Myocytes, Cardiac,
pubmed-meshheading:16038707-Receptors, Thrombin,
pubmed-meshheading:16038707-Recombinant Proteins,
pubmed-meshheading:16038707-Thrombin
|
pubmed:year |
2005
|
pubmed:articleTitle |
Thrombin increases cardiomyocyte acute cell death after ischemia and reperfusion.
|
pubmed:affiliation |
Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|